Trade VERA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Vera Therapeutics, Inc. Class A (VERA) is trading at US$25.45, down 4.86% today as of Nov 20, 16:00 EST. The company has a market capitalisation of US$1.84B. Over the past 52 weeks, VERA has traded between US$25.08 and US$56.05. On Syfe you can trade VERA with $0 commission and add it to your watchlist.
| Previous close | US$26.75 |
|---|---|
| Market cap | US$1.84B |
| 52-week range | US$25.08 – US$56.05 |
| Volume | 1.37M |
| Exchange | US |
Vera Therapeutics, Inc. Class A
Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.
Year: 2021
Leerink Partners Initiates Vera Therapeutics at Market Perform With $34 Price Target
Oct 12, 11:12 AM · MT Newswires
BofA Securities Adjusts Vera Therapeutics Price Target to $60 From $66, Maintains Buy Rating
Oct 9, 2:17 PM · MT Newswires
Top Midday Stories: Waystar Reportedly Mulling Potential Sale; Intel-Backed Altera Says Parent Company Files Confidentially for IPO
Sep 15, 3:42 PM · MT Newswires
Vera Therapeutics, Inc. Class A (VERA) stock is trading at US$25.45, -4.86% from the previous close of US$26.75.
The market cap for Vera Therapeutics, Inc. Class A (VERA) stock is approximately US$1.84B.
The 52-week high for Vera Therapeutics, Inc. Class A (VERA) stock is US$56.05.
The 52-week low for Vera Therapeutics, Inc. Class A (VERA) stock is US$25.08.
Vera Therapeutics, Inc. Class A (VERA) does not currently pay a dividend.
Stay on top of VERA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore